TITLE

New drug Herceptin shrinks breast tumors

PUB. DATE
June 1998
SOURCE
Jet;06/08/98, Vol. 94 Issue 2, p20
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on the drug Herceptin, which shrinks breast tumors. Results of a study conducted on the use of the drug by women; Manufacturer of the drug; Side effects of Herceptin.
ACCESSION #
724732

 

Related Articles

  • Surgical office-based ultrasound of the breast. Staren, Edgar D. // American Surgeon;Jul1995, Vol. 61 Issue 7, p619 

    Evaluates the influence of office-based ultrasound (US) on the management of palpable, new or increasing size, mammogram-detected breast masses. Description of patients' condition; Undergoing of US-guided aspiration and/or biopsy of breast mass; Patients with fibroadenoma; Accuracy of diagnosis.

  • Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical... Tafra, Lorraine; Essner, Richard // American Surgeon;May1996, Vol. 62 Issue 5, p395 

    Characterizes the clinical and pathologic tumor status and the outcome of women undergoing breast-conserving therapy for invasive carcinomas detected by either mammography or physical exam. Axillary node involvement; Risk of local recurrence; Implications of tumor-free operative margins.

  • Lymphoedema after treatment for breast cancer.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/2/2011, Vol. 343 Issue 7813, p30 

    The article discusses lymphoedema, a disease which develops after a woman with breast cancer is treated.

  • HER2 testing in patients with breast cancer: Must be performed in a timely manner to facilitate appropriate treatment decisions. Dixon, J. Michael; Wilson, Victoria; Verrill, Mark; Symmans, W. Fraser // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/23/2012, Vol. 344 Issue 7862, p9 

    The authors discuss the need for timely manner testing of Human Epidermal Growth Factor Receptor 2 (HER2) in breast cancer patients, to facilitate appropriate treatment decisions. Various methods used for the detection of HER2 overexpression in cancerous cells including immunohistochemical test,...

  • Breast cancer and you. Washington, Harriet // Essence (Essence);Oct96, Vol. 27 Issue 6, p28 

    Discusses topics about breast cancer. Importance of knowing how to detect the disease and knowing the risk factors; Most effective way of detecting breast cancer; Best defense against breast cancer.

  • Bringing core biopsy into a surgical practice. Roe, S. Michael; Sumida, Michael P. // American Surgeon;Feb1996, Vol. 62 Issue 2, p113 

    Reports on the acceptance of the use of invasive diagnostic techniques when assessing patients with breast disease, by physicians. Incorporation of stereotactic core needle biopsy and ultrasound-guided core biopsy for evaluation of patients; Benefits of core breast biopsy.

  • Breast Cancer -- Your Treatment Choices. Morrison, Jan // Cancer Nursing Practice;Nov2013, Vol. 12 Issue 9, p10 

    The article reviews the book "Breast Cancer: Your Treatment Choices," by Terry Priestman.

  • Study finds milk duct tumors may not require mastectomies. Coleman, Brenda C. // Hudson Valley Business Journal;4/29/96, Vol. 6 Issue 52, p29 

    Reports on the results of a study that milk duct tumors may not require mastectomies. Treatment of ductal carcinoma in situ; Advantages of early detection of breast cancer; Mammography.

  • HOMEOPATHY AND BREAST CANCER? ROSS, DIANA // Natural Solutions;Oct2010, Issue 128, p7 

    A letter to the editor is presented in response to the article "Homeopathy Blasts Breast Cancer Cells," by Melaina Juntti in the June, 2010 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics